Prostate cancer screening often detects indolent cancers—defined as those which would never cause morbidity or mortality if left undetected and untreated. Unnecessary treatment of indolent cancer is a problem associated with this 'overdetection'. Active surveillance is a management strategy for low-risk cancers which can decrease the overtreatment burden.
- Jared M. Whitson
- Sima P. Porten
- Peter R. Carroll
